IQWiG Autumn Symposium

Focus on low-value care: Insights and options for action

Register now for the IQWiG Autumn Symposium on 20 November 2026 in Cologne!

Cost pressures within the health care system are mounting, making the issue of low-value care all the more pressing: but how can medical services that offer little or no benefit to patients and unnecessarily tie up resources be systematically identified in the first place? This question is the focus of this year’s IQWiG Autumn Symposium.

The first session will focus on evidence and the scientific basis: Verena Vogt, Professor of Quantitative Health Services Research at Jena University Hospital and a member of the Health Finance Commission, will demonstrate how to measure low-value care using routine statutory health insurance data. Simone van Dulmen from Radboud University Medical Center in Nijmegen will report on experiences from the Netherlands. Jean-François Chenot, Head of the Department of General Practice at Greifswald University Hospital, will discuss the tension between practical reason, evidence and regulatory specifications.

In the second part, the speakers will shed light on low-value care from various perspectives: Franz Knieps, long-standing CEO of the BKK (company health insurance funds) umbrella organisation, will explain the regulatory perspective. Gregor Bornes from ‘Gesundheitsladen Köln’ will outline the patients’ perspective, whilst Matthias Wilken from the BPI (German industry association for the pharmaceutical industry) will set out that of the pharmaceutical industry. Claudia Spies from Berlin’s Charité hospital will discuss the limits of low-value care for the seriously ill.

The event will conclude with a moderated dialogue involving all the speakers, followed by a closing discussion involving the audience on the specific next steps towards identifying and reducing low-value care in Germany.

The registration deadline is 8 November 2026

Register via Conftool.net (German only)

Programme | Friday, 20 November 2026

from 12:00 Informal onboarding session with snacks and drinks
12:30 – 12:40 Welcome
IQWiG Institute Management and moderation team urban & saal
12:40 – 13:10 Prof. Dr Verena Vogt – Jena University Hospital
Measuring low-value care using routine statutory health insurance data: status quo and outlook
13:10 – 13:40 Dr. Simone van Dulmen – Radboud University, Netherlands
Challenges and opportunities to reduce low-value care. Lessons from the Netherlands.
13:40 – 14:10 Prof. Dr Jean-François Chenot – Greifswald University Hospital
Practical reason, evidence and regulatory specifications: sometimes contradictory
14:10 – 15:00 Lunchtime snack
15:00 – 15:20 Franz Knieps – Senior Adviser
The regulatory perspective
15:20 – 15:40 Gregor Bornes – Gesundheitsladen e.V.
The patient perspective
15:40 – 16:00 Prof. Dr Claudia Spies – Charité Universitätsmedizin Berlin
The limits of an economic perspective / Low-value care for the seriously ill
16:00 – 16:20 Dr Matthias Wilken – BPI e.V.
The pharmaceutical industry’s perspective
16:20 – 16:45 Coffee Break
16:45 – 17:45 Closing discussion
What are the specific next steps from identifying to reducing low-value care in Germany?
17:45 – 18:00 Summary and close
IQWiG Institute Management and moderation team urban & saal
18:00 – 23:00 Evening event with buffet and drinks

Programme and Speaker CVs

Current and controversial aspects in medicine and health politics are regular topics at the annual Autumn Symposium organised by the Institute for Quality and Efficiency in Health Care. The spectrum of speakers is usually as broad as the range of topics and includes epidemiologists and oncologists, as well as health economists and lawyers.

Presentations from previous "IQWiG Autumn Symposium" Events

2024: Science communication with a difference
2023: The challenge of Rare Diseases
2022: “Diagnostics: Why ‘accurate’ is not enough”
2021: Commercialization in health care – Time for health economic evaluations?
2020: canceled
2019: Between scalpel and algorithm - evidence-based surgery
2018: Sour fruits from the tree of knowledge? How we communicate evidence
2017: Transfer of evidence – Game without frontiers?
2016: More light than shadow? Beneficial and hindering factors for successful clinical studies
2015: Real-world data for benefit assessments: How can registries and routine data contribute?
2014: Evidence-based health care: Where should the journey go to? / What can IQWiG contribute to the challenges and what can it do better?
2013: Quality of life in health care: Do we know what we are doing?
2012: Cancer: Is everything different? / Can less be more?
2011: Methodology: between regulations and arbitrariness / Personal responsibility
2010: Balancing of benefits and harms in health system decision-making / Data transparency as a precondition to the informed balancing of benefits and harms
2009: Medicine - belief and knowledge / Health care system - experiencing and funding it
2008: Assessment of the Benefits and Harms of Medical Interventions / Science, Society, and the Individual
2007: Knowledge as the basis of physicians' and patients' decision-making / The financial significance of disease and health
2006: Hopes and Errors in Medicine / Costs, Quality and Justice in the Health Care System
2005: Diagnosis, Screening and Patient Oriented Research / Insight and Decision in Medicine